We verified these findings, demonstrating increased SELENBP1 levels in the PFC of patients with schizophrenia compared with those of controls across diverse demographic and postmortem factors, including sex, race, age, PMI, and tissue pH (Fig. 1 and SI Appendix, Tables S1 and S2). This evidence concerns the gene SELENBP1 and schizophrenia.